AstraZeneca\'s Imfinzi immunotherapy combo fails to show benefit in lung cancer httpbit.ly2BaJnvf cancer LungCancer pharmapic.twitter.com2EznhWhFqv

AstraZeneca's Imfinzi immunotherapy combo fails to show benefit in lung cancer http://bit.ly/2BaJnvf  #cancer #LungCancer #pharmapic.twitter.com/2EznhWhFqv

05:54 EST 16 Nov 2018 | Pharmafile

AstraZeneca's Imfinzi immunotherapy combo fails to show benefit in lung cancer http://bit.ly/2BaJnvf  #cancer #LungCancer #pharma pic.twitter.com/2EznhWhFqv

More From BioPortfolio on "AstraZeneca's Imfinzi immunotherapy combo fails to show benefit in lung cancer http://bit.ly/2BaJnvf  #cancer #LungCancer #pharmapic.twitter.com/2EznhWhFqv"